In this case-control study, we found an inverse association between fish consumption and chance of breast cancer, indicating that a higher fish intake was associated with a lower odds of breast cancer. Despite the absence of a significant association in premenopausal women, we found a protective association between normal weight and postmenopausal women.
According to the World Health Organization (WHO) report, over 2.3 million women will be diagnosed with breast cancer by 2050 [31, 32]. Breast cancer has been recognized as the most common kind of cancer among Iranian women and is associated with a significant burden of mortality, based on crude mortality statistics. [33, 34]. Previous studies demonstrated that diet exerts an effect on the risk of developing breast cancer [35]. Even though a variety of dietary components have been studied in relation to breast cancer, fish consumption has gotten little attention to this point. The present study revealed that fish consumption was associated with a reduced risk of breast cancer, particularly in postmenopausal women. In keeping with our findings, a Korean case-control study indicated a protective association between fish intake and breast cancer risk [16]. This was also observed in a prospective study of 35,298 Chinese Singaporean women followed for five years. Also reported is the beneficial relationship between fish consumption and other forms of cancer, including colorectal, liver, and lung cancers [36–38]. In contrast to our findings, Kiyabu et al. [39] found no association between total fish consumption and breast cancer risk in a 14-year prospective analysis of Japanese women. Another cohort study of British women revealed no relationship between fish consumption and breast cancer incidence [40]. In addition, a prospective cohort study of Danish postmenopausal women revealed that women with a higher fish consumption had a greater risk of developing breast cancer [18]. Various factors, including sample size, considering several potential confounders, cancer stage at diagnosis, different cooking methods across various populations, different ranges of fish consumption, and different types of fish, such as salted, oily, and lean fish, may explain these divergent findings across different studies in different regions [41] as well as different methodologies used to examine fish intake and breast cancer. Furthermore, the role of measurement errors in dietary assessment cannot be ignored [27].
Multiple mechanisms may explain the beneficial association between fish consumption and breast cancer risk. Previous research has linked the preventive effect of fish against breast cancer to its high omega-3 PUFA concentration [16, 19]. Omega-3 PUFA may reduce breast cancer risk by downregulating the inflammatory cascade, increasing fatty acid (FA) breakdown while decreasing FA production, causing apoptosis and inhibiting cell proliferation [42, 43]. In addition, n-3 PUFA could reduce estrogen synthesis, hence inhibiting estrogen-induced cell proliferation [44, 45]. Specifically, studies employing cell lines and mouse models have demonstrated that n-3 PUFA inhibit the formation of breast tumors [46]. In addition, the anti-inflammatory properties of EPA (Eicosapentaenoic acid) and DHA (Docosahexaenoic acid) and their ability to alter the fatty acid structure of cell membranes make susceptible individuals’ suitable candidates for breast cancer prevention [43, 47]. Fish also include essential micronutrients such as magnesium, phosphate, potassium, and protein, which might have a role in this regard [48–50]. In addition, fish has been recognized as a key source of B-vitamins, including riboflavin, niacin, and folate [51], which the breast cancer-preventive benefits of these nutrients have been shown in prior studies [52–54]. Fish may be contaminated by environmental contaminants such as heavy metals, pesticides, or organic pollutants, which may have estrogenic effects [55]. These constituents in fish may diminish or even negate the health benefits of eating fish [56]. Because these chemicals accumulate in fat tissue, one would expect the increased risk to be greater with higher eating of fatty fish compared to ingestion of lean fish [55]. In the current study, after stratification by menopausal status, the protective link of fish consumption remained significant for postmenopausal women but was no longer significant for premenopausal women. This discrepant outcome may be explained by the small number of premenopausal women in our study (23% of controls and 12% of breast cancer patients). Additionally, premenopausal and postmenopausal women differ in reproductive and adiposity characteristics that have opposing effects on breast tissue sensitivity [57, 58].
Several potential strengths of the current investigation must be highlighted. Accurate assessment of study exposure and adjustment for a wide range of confounding variables, an acceptable sample size, and being the first study among women in the Middle East can be noted. In addition, newly diagnosed cases of breast cancer were included in this investigation. Therefore, changes in dietary intakes were less likely. we also calculated energy adjusted amount of fish intake in this study, which can help reduce participants’ misclassification. The limitations of this study, however, should be considered when interpreting its findings. A major limitation of this study is cancer treatment before dietary assessments. Therefore, the precision of acquired data indicating fish frequency may be impacted by a random error known as diagnostic bias and due to the nature of case-control studies, our study was susceptible to selection and recall biases, which would make it impossible to assume causality. Furthermore, as with other epidemiological studies, the use of FFQ may result in participants’ misclassification. Although we used a validated FFQ for dietary intake assessment, this FFQ was validated in a nonmalignant population, so there is cause for concern for populations with cancer and during cancer treatment. Second, the relationship between breast cancer and nutrition is complicated, particularly because breast cancer is a multifactorial and complex disease. Third, we also did not investigate the types of fish (fatty or lean), their sources (sea/salty water or fresh water), or their preparation methods (boiled, fried, salted, canned, etc.), which could have an impact on the observed association. It is suggested that these characteristics be taken into account in future studies on fish consumption. Fourth, we did not collect information on estrogen or progesterone receptor status, as well as breast cancer stage. Fifth, breast cancer patients may recall their past diet differently in the context of their cancer diagnosis, or they might have altered their diet prior to diagnosis as a result of early signs of the disease. Sixth, the IPAQ questionnaire used in our research assesses physical activities performed by individuals during the previous nine days, which does not account for total lifetime physical activity. The questionnaire assesses current activity levels across various domains of physical activity during a typical week. Consequently, our investigation did not assess patterns of lifetime physical activity. In addition, sedentary behavior data were not considered in our survey, and we focused primarily on assessing various domains of physical activity, such as work-related activities, transportation, domestic chores, and leisure activities. Seventh, it is impossible to rule out the possibility of residual confounding in this study as in all observational studies. Finally, over 80% of the population were postmenopausal women, and it would be interesting to conduct additional research on premenopausal women.
The current case-control study found a statistically significant inverse association between fish consumption and likelihood of having breast cancer, especially in postmenopausal women. This finding is significant in light of the region's low fish consumption. These data support the role of food in breast cancer prevention.